FDO Partners’s Bristol-Myers Squibb BMY Stock Holding History

FDO Partners’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-26,276	Closed	-$1.46M	–	223
2017 Q2	$1.46M	Buy	26,276 +9,003	+52%	+$490K	0.31%	138
2017 Q1	$939K	Buy	+17,273	New	+$947K	0.23%	146
2016 Q4	–	Sell	-25,836	Closed	-$1.39M	–	201
2016 Q3	$1.39M	Buy	+25,836	New	+$1.66M	0.6%	68
2016 Q1	–	Sell	-20,716	Closed	-$1.43M	–	256
2015 Q4	$1.43M	Buy	+20,716	New	+$1.37M	0.81%	19

Other funds holding BMY

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FDO Partners's BMY Position: Q3 2017 in Review

FDO Partners sold out of Bristol-Myers Squibb (BMY) in Q3 2017, closing a stake of 26,276 shares — an estimated $1.46M sold.

FDO Partners first reported a position in BMY in Q4 2015 and held it in 4 quarters. The position peaked at $1.46M in Q2 2017. 1,642 funds tracked by Wall St. Rank hold BMY as of Q3 2017.

FDO Partners reported no remaining Bristol-Myers Squibb position as of Q3 2017 after selling out during the quarter.
FDO Partners sold 26,276 Bristol-Myers Squibb shares in Q3 2017, an estimated $1.46M.
FDO Partners first reported a position in Bristol-Myers Squibb in Q4 2015 and held it in 4 quarters.
FDO Partners's Bristol-Myers Squibb position peaked at $1.46M in Q2 2017.
1,642 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2017.

Based on FDO Partners's 13F filing for Q3 2017, filed 13 Nov 2017.